CellSource Co Ltd
TSE:4880
CellSource Co Ltd
Operating Expenses
CellSource Co Ltd
Operating Expenses Peer Comparison
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CellSource Co Ltd
TSE:4880
|
Operating Expenses
-¥2B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
CMIC Holdings Co Ltd
TSE:2309
|
Operating Expenses
-¥15.3B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-7%
|
|
S
|
Shin Nippon Biomedical Laboratories Ltd
TSE:2395
|
Operating Expenses
-¥10.1B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-5%
|
Medinet Co Ltd
TSE:2370
|
Operating Expenses
-¥1.5B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
3%
|
|
Linical Co Ltd
TSE:2183
|
Operating Expenses
-¥3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-15%
|
|
WDB coco Co Ltd
TSE:7079
|
Operating Expenses
-¥503.4m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
See Also
What is CellSource Co Ltd's Operating Expenses?
Operating Expenses
-2B
JPY
Based on the financial report for Oct 31, 2023, CellSource Co Ltd's Operating Expenses amounts to -2B JPY.
What is CellSource Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-28%
Over the last year, the Operating Expenses growth was -31%. The average annual Operating Expenses growth rates for CellSource Co Ltd have been -33% over the past three years , -28% over the past five years .